没有核酶的基因组编辑为编辑的肝细胞赋予了增殖优势,并纠正了威尔逊病
Agnese Padula1, Michele Spinelli2, Edoardo Nusco1
1Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
JCI insight
|September 14, 2023
概括
无核酶基因组编辑为威尔逊病 (WD) 提供了一个有前途的新疗法,这是一种遗传铜代谢障碍. 这种方法使用AAV载体来整合一个迷你ATP7B基因,改善肝功能,并可能提供更安全的长期治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因治疗 基因治疗
- 遗传学 遗传学 是一个
背景情况:
- 肝脏疾病的经典基因替代疗法受到肝细胞增殖和基因毒性风险的限制.
- 威尔逊病 (WD) 涉及由于ATP7B基因突变而导致有毒铜积累,导致严重的肝脏和大脑损伤.
- 在至少25%的肝细胞中恢复ATP7B功能是WD治疗所必需的,这种速度通常无法在当前的基因组编辑中实现.
研究的目的:
- 为威尔逊病开发和评估一种无核酶,肝脏导向的基因组编辑策略.
- 在WD小鼠模型中评估AAV介导的mini-ATP7BcDNA向集成的有效性.
- 将这种新方法的治疗益处与现有治疗方法进行比较.
主要方法:
- 基关联病毒载体 (AAV) 介导的针对性整合无促进体迷你ATP7BcDNA进入白蛋白 (Alb) 位点.
- 在两个威尔逊病小鼠模型中应用AAV-Alb-mini-ATP7B载体.
- 组合疗法涉及基因组编辑和铜化剂.
主要成果:
- 通过基因组编辑的肝细胞观察到广泛的肝脏重新填充,具有增殖优势.
- 在接受治疗的WD小鼠中,肝损伤显著改善,铜代谢改善.
- 结合基因组编辑和化疗法,与单独化疗法相比,显示出更好的疾病改善.
结论:
- 使用AAV介导的向整合进行无核酶基因组编辑是威尔逊病的可行治疗策略.
- 这种方法促进了纠正的肝细胞的扩张,提供了潜在的长期解决方案.
- 这些发现表明,对于WD来说,传统的基因替代疗法是一种更安全,更持久的替代方案.
相关概念视频
CRISPR
52.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.2K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K


